Advertisement

Ads Placeholder
Loading...

Cronos Australia Limited

CAU.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.54
$0.00(0.00%)
Australian Market opens in 61h 52m

Cronos Australia Limited Fundamental Analysis

Cronos Australia Limited (CAU.AX) shows weak financial fundamentals with a PE ratio of 43.07, profit margin of 9.03%, and ROE of 34.17%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE34.17%
PEG Ratio0.43
Current Ratio2.27

Areas of Concern

No major concerns flagged.
We analyze CAU.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 68.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
68.6/100

We analyze CAU.AX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

CAU.AX demonstrates superior asset utilization.

ROA > 10%
14.11%

Valuation Score

Moderate

CAU.AX shows balanced valuation metrics.

PE < 25
43.07
PEG Ratio < 2
0.43

Growth Score

Weak

CAU.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CAU.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.19
Current Ratio > 1
2.27

Profitability Score

Moderate

CAU.AX maintains healthy but balanced margins.

ROE > 15%
34.17%
Net Margin ≥ 15%
9.03%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CAU.AX Expensive or Cheap?

P/E Ratio

CAU.AX trades at 43.07 times earnings. This suggests a premium valuation.

43.07

PEG Ratio

When adjusting for growth, CAU.AX's PEG of 0.43 indicates potential undervaluation.

0.43

Price to Book

The market values Cronos Australia Limited at 9.98 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

9.98

EV/EBITDA

Enterprise value stands at 28.66 times EBITDA. This signals the market has high growth expectations.

28.66

How Well Does CAU.AX Make Money?

Net Profit Margin

For every $100 in sales, Cronos Australia Limited keeps $9.03 as profit after all expenses.

9.03%

Operating Margin

Core operations generate 15.21 in profit for every $100 in revenue, before interest and taxes.

15.21%

ROE

Management delivers $34.17 in profit for every $100 of shareholder equity.

34.17%

ROA

Cronos Australia Limited generates $14.11 in profit for every $100 in assets, demonstrating efficient asset deployment.

14.11%

Following the Money - Real Cash Generation

Operating Cash Flow

Cronos Australia Limited produces operating cash flow of $7.77M, showing steady but balanced cash generation.

$7.77M

Free Cash Flow

Cronos Australia Limited produces free cash flow of $7.33M, offering steady but limited capital for shareholder returns and expansion.

$7.33M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CAU.AX converts 2.11% of its market value into free cash.

2.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

43.07

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.43

vs 25 benchmark

P/B Ratio

Price to book value ratio

9.98

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.49

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.19

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.27

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.34

vs 25 benchmark

ROA

Return on assets percentage

0.14

vs 25 benchmark

ROCE

Return on capital employed

0.33

vs 25 benchmark

How CAU.AX Stacks Against Its Sector Peers

MetricCAU.AX ValueSector AveragePerformance
P/E Ratio43.0728.54 Worse (Expensive)
ROE34.17%738.00% Weak
Net Margin9.03%-43982.00% (disorted) Weak
Debt/Equity0.190.34 Strong (Low Leverage)
Current Ratio2.272806.01 Strong Liquidity
ROA14.11%-14624.00% (disorted) Strong

CAU.AX outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cronos Australia Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ